Gráfico del Precio de Acciones APUS
APUS Ganando
Apimeds Pharmaceuticals US Inc
$1.88
0%
$0
Al cierre: Apr 16, 16:00:00 GMT-4
$1.88
0%
$0
Mercado Posterior: Apr 16, 18:08:32 GMT-4
Atrás
Apimeds Pharmaceuticals US Inc (APUS) Ganando
Estadísticas clave
Cierre Anterior
$1.88
Precio de apertura
$1.69
Rango del día
$1.69 - $1.88
Rango de 52 semanas
$1.6 - $40.31
Volumen
31.5K
Volumen promedio
17.9K
Rendimiento de dividendos
--
EPS (TTM)
--
Cap. de mercado
$23.6M
¿Qué es APUS?
Apimeds Pharmaceuticals US, Inc. is a clinical stage biopharmaceutical company that engages in the development of Apitox, an intradermally administered bee venom-based toxin. The company is headquartered in Matawan, New Jersey and currently employs 2 full-time employees. The company went IPO on 2025-05-09. The firm is engaged in developing Apitox, an intradermally administered bee venom-based toxin. The company is focused on developing Apitox in the treatment of inflammatory conditions in the United States, specifically osteoarthritis and multiple sclerosis. Its subsidiary, MindWave Innovations Inc, is a provider of institutional digital asset treasury (DAT) solutions.
Características
Recursos
© 2026 Finture Development Limited. Todos los derechos reservados.
